The American Medical Association (AMA) has adopted new policies aimed at increasing access to obesity care drugs, reducing the corporatisation of healthcare and urging flexibility in the treatment of opioid use disorder. Key policies include advocating health insurance coverage for obesity treatment drugs, resisting corporate encroachment into medical practices, and calling for the elimination of buprenorphine treatment dose limits for patients with opioid use disorder.
Changes Are Likely on the Horizon for the Federal Healthcare Portfolio in Areas Including Cybersecurity and Regulatory Enforcement | Bond Schoeneck & King PLLC
Republican victories in recent US federal elections could affect how the healthcare sector will be regulated. Changes are expected as the focus shifts from a
